Haemonetics Corp
HAE- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000313143
No open-market purchases or sales by Haemonetics Corp insiders were filed in the last 90 days; 330 institutions reported holding it in 13F filings for Q2 2026, worth $3.72B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Haemonetics Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 269 | 5 | 294 | +30 |
| Shares | 51.7M | 29.9K | 50.4M | −1.35M (−2.6%) |
| Value | $3.83B | $2.21M | $3.96B | +$132.8M (+3.5%) |
5 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (50)
Institutions that held Haemonetics Corp at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (20)
Institutions that held Haemonetics Corp at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Balyasny Asset Management LLC | 243,677 | $18.0M |
| River Road Asset Management, LLC | 93,995 | $6.96M |
| Aurora Investment Counsel | 22,059 | $1.63M |
| Capital Fund Management S.A. | 16,728 | $1.24M |
| Algert Global LLC | 11,524 | $853.0K |
| AlphaCrest Capital Management LLC | 8,883 | $658.0K |
| D. E. Shaw & Co., Inc. | 7,998 | $592.0K |
| Banque Cantonale Vaudoise | 5,451 | $404.0K |
| FORA Capital, LLC | 4,772 | $353.0K |
| Two Sigma Securities, LLC | 2,996 | $222.0K |
| Teza Capital Management LLC | 2,850 | $211.0K |
| PEAK6 Investments LLC | 2,818 | $209.0K |
| Simplex Trading, LLC | 1,495 | $110.0K |
| Ellis Investment Partners, LLC | 912 | $67.0K |
| Group One Trading, L.P. | 630 | $47.0K |
| Brown Brothers Harriman & Co | 317 | $23.0K |
| Kenfarb & Co. | 100 | $7.00K |
| Almanack Investment Partners, LLC. | 60 | $4.00K |
| Wagner Wealth Management, LLC | 28 | $2.00K |
| Absolute Capital Management, LLC | 4 | $294 |
Not filed for Q4 2022 yet (5)
Institutions that held Haemonetics Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Walthausen & Co., LLC | 19,226 | $1.42M |
| Eaton Vance Management | 8,004 | $593.0K |
| USA Financial Portformulas Corp | 1,232 | $91.0K |
| FourThought Financial, LLC | 1,113 | $82.0K |
| Wipfli Financial Advisors LLC, | 336 | $25.0K |